Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis

Fig. 1

PRISMA flowchart of systemic literature review update. CADTH, Canadian Agency for Drugs and Technologies in Health; CSR, clinical study report; FDA, Food and Drug Administration; NCT, National Institute of Health clinical trial results published on ClinicalTrials.gov; NMA, network meta-analysis; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; Pubs, published articles; RCT, randomized controlled trial; SLR, systemic literature review; TE, treatment experienced; TN, treatment naïve

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us